Global Lyophilization Services For Biopharmaceuticals Market – Regional Analysis
On the basis of region, the global Lyophilization Services For Biopharmaceuticals Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to dominate the global Lyophilization Services For Biopharmaceuticals Market and account for the largest share during forecast period owing to an increasing number of strategic mergers and acquisitions among players with regards to biopharmaceutical stabilization. For instance, in 2012, Anteco Pharma is a leader in lyophilization and freeze drying solutions for the specialty food, pharmaceutical industry, expanded its territory through a 25,000-square-foot addition to its manufacturing facility in Lodi, Wis, U.S This expansion is focused on manufacture of pharmaceutical and medical devices. Key players in the North America lyophilisation service markets are Anteco Pharma LLC, Axcellerate Pharma LLC, Berkshire Sterile Manufacturing, Inc., Jubilant HollisterStier LLC, Lyophilization Technology, Inc. (LTI). These factors are propelling the growth of Lyophilization Services For Biopharmaceuticals Market in North America.
Moreover, Key players in the Europe lyophilisation service market are GILYOS GmbH, Lyophilization Services of New England, Inc., and others. Europe is projected to witness sustainable growth in the global biopharmaceutical stabilisation (lyophilisation) service market during the forecast period. For instance, in February 2020, Lyophilization Services of New England (LSNE) Contract Manufacturing, a contract development and manufacturing organization, expanded its company through a 26,000 square foot addition to its existing seven commerce facilities in Bedford, New Hampshire campus, U.S. This expansion has further increased LSNE's commercial drug product manufacturing capacity. The addition will feature a high-speed six head Bausch+Ströbel aseptic vial filling line, Ziel isolator, and multiple large-scale commercial freeze-dryers with automated loading/unloading. These factors are propelling the growth of Lyophilization Services For Biopharmaceuticals Market in Europe.
Furthermore, the market in Asia Pacific particularly in India and China are expected to contribute significantly to the growth of the global lyophilization services market due to the growing number of contract manufacturing units. Countries such as India, China, and South Korea are two of the biggest countries operating in the market with high expectancy to dominate biopharmaceutical stabilization market in Asia pacific. For instance, in South Korea according to Korea Biomedical Review in 2020, Samsung Biologics said that it has signed a letter of intent for a contract manufacturing organization (CMO) deal worth 381 billion won (US$317.1 million) with a European client. The company said it would disclose its European client's name after Dec. 31, 2023, due to confidentiality reasons. Samsung Biologics plans to produce the client’s biopharmaceutical products at its third plant in Songdo, an international business zone in the western port city of Incheon, South Korea. Key players in Asia Pacific are Piramal Pharma Solutions Inc. and Dr Reddy's Laboratories. These factors are propelling the growth of the Lyophilization Services For Biopharmaceuticals Market in Asia Pacific.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients